Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors is a research paper published in Frontiers in Toxicology (2023). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R21HD106842-01A1
Functional mechanism underlying Dolutegravir (DTG)-associated developmental CNS abnormalities: Inhibition of matrix metalloproteinases activities
National Institutes of Health
Grant: 5R01AI158160-03
LASER ART for PreP
National Institutes of Health
Grant: 5R21MH128123-02
CNS HIV Theranostics Based on Intrinsic CEST Contrasts of Antiretroviral Drugs
National Institutes of Health
Grant: 1R01AI145542-01A1
Prodrug Formulations Create Sustained Release Antiretrovirals
NIAID NIH HHS
Grant: R01 AI158160
NINDS NIH HHS
Grant: R01 NS034239
NICHD NIH HHS
Grant: R21 HD106842
NINDS NIH HHS
Grant: T32 NS105594
FWCI
2.23
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals